BORTEZOMIB IS ABLE TO INACTIVATE NF-KB AND DOWN-REGULATE WT1 GENE IN P39 CELL LINE: A POSSIBLE USE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES?


Galimberti S., Canestraro M., Savli H., Palumbo G. A. , Nagy B., Di Raimondo F., ...More

13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.280 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 93
  • City: Copenhagen
  • Country: Denmark
  • Page Numbers: pp.280